NutriTech: Application of New Technologies and Tools to Nutrition Research
Study Details
Study Description
Brief Summary
The overall objective of the research is to develop new methods for studying the link between diet, health and disease.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
The enquiry consists of two part. A metabolomic biomarker discovery study followed by a randomised controlled trial of moderate dietary induced weight loss.
A cohort of moderately overweight men and women will undergo a metabolomic study follow by randomised controlled trial of a healthy diet with a 20% energy restriction for a 12 week period. This intervention will improve the volunteer's body composition and reduce their risk of developing diabetes.
Extensive tests will be conducted before and after the dietary intervention using emerging technologies with current state-of-the-art methods. These tests will monitor the numerous physiological adaptations that have occurred on a gene, cell, organ and organismic level.
The study will, therefore, aim for a scientific breakthrough by developing a series of novel biological "markers" that can accurately determine an individual's health status.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Life style advice reduce energy intake by 20% less than estimated energy expenditure. |
Behavioral: Metabolomic and Energy Intake Restriction
Metabolomic inquiry followed by a 12 week energy intake restriction. This study is part of a very large European study called EPIC. Only the results by Lee et al. 2016 have been presented here. The results of the study published by Cheung 2017 are from a different study. therefore the entries for the results are correct. For this particular study, participants were not randomly assigned to one of five different diets; red meat, fish, poultry, processed meat or a supplement and vegetarian option. In summary, both studies (lee and cheung) are considered as separate trials and results of the first phase where participants were assigned to one of five different diets, are reported separately. Unfortunately no different NCT number is available.
Other Names:
|
Active Comparator: UK background diet Diet where energy intake will be matched with estimated energy expenditure. |
Behavioral: Metabolomic and Energy Intake Restriction
Metabolomic inquiry followed by a 12 week energy intake restriction. This study is part of a very large European study called EPIC. Only the results by Lee et al. 2016 have been presented here. The results of the study published by Cheung 2017 are from a different study. therefore the entries for the results are correct. For this particular study, participants were not randomly assigned to one of five different diets; red meat, fish, poultry, processed meat or a supplement and vegetarian option. In summary, both studies (lee and cheung) are considered as separate trials and results of the first phase where participants were assigned to one of five different diets, are reported separately. Unfortunately no different NCT number is available.
Other Names:
|
Other: Metabolomic inquiry This inquiry took place prior to the randomized controlled trial and include 50 volunteers who will then be asked to volunteers of the weight loss study. Were randomly assigned to one of five different diets; red meat, fish, poultry, processed meat or a supplement and vegetarian option. |
Behavioral: Metabolomic and Energy Intake Restriction
Metabolomic inquiry followed by a 12 week energy intake restriction. This study is part of a very large European study called EPIC. Only the results by Lee et al. 2016 have been presented here. The results of the study published by Cheung 2017 are from a different study. therefore the entries for the results are correct. For this particular study, participants were not randomly assigned to one of five different diets; red meat, fish, poultry, processed meat or a supplement and vegetarian option. In summary, both studies (lee and cheung) are considered as separate trials and results of the first phase where participants were assigned to one of five different diets, are reported separately. Unfortunately no different NCT number is available.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Insulin Sensitivity [Baseline, 12 weeks]
Glucose Infusion rate assessed by the euglycemic hyperinsulinemic clamp. Insulin Sensitivity assessment was only performed in the "Exercise" and "Exercise, Control" groups. No data were collected for this Outcome from the remaining groups.
- Metabolomic Biomarker Discovery - Changes in Blood Plasma Cholesterol [Baseline, 12 weeks]
Changes in blood plasma cholesterol in mg/dL- baseline to 12 weeks, after treatment. Statistical Analysis was performed only for the "Diet" Arm/Group.
Secondary Outcome Measures
- Body Composition [Baseline, 12 weeks]
Body Composition assessed by BMI
- Changes in Adipocyte Morphology [12 weeks]
Percentage Change in total adipose tissue assessed by MRI
- Genome Integrity (DNA Methylation and Telomere Length) [12 weeks]
- Body Weight [Baseline, 12 weeks]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Healthy overweight volunteers (body mass index (BMI) of 25-30 kg/m2)
-
Age between 50-65 years
Exclusion Criteria:
-
Weight change of ≥ 3kg in the preceding 3 months
-
Current smokers
-
Substance abuse
-
Excess alcohol intake
-
Pregnancy
-
Diabetes
-
Cardiovascular disease
-
Cancer
-
Gastrointestinal disease e.g. inflammatory bowel disease or irritable bowel syndrome
-
Kidney disease
-
Liver disease
-
Pancreatitis
-
Have any metallic or magnetic implants such as pacemakers
-
Use of medications likely to interfere with energy metabolism, appetite regulation and hormonal balance, including: anti inflammatory drugs or steroids, antibiotics, androgens, phenytoin, erythromycin or thyroid hormones.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Imperial College London | London | United Kingdom | W12 0NN |
Sponsors and Collaborators
- Imperial College London
Investigators
- Principal Investigator: Gary S Frost, Imperial College London
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 12/L0/0139
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Exercise | Diet | Exercise, Control | Diet, Control |
---|---|---|---|---|
Arm/Group Description | An overweight/dysglycemic group 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks | overweight/ obese subjects with normal glucose metabolism with energy restriction, 20% reduced intake of energy from food for 12 weeks. Energy intake was matched with estimated energy expenditure | An overweight with no dysglycemia 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks | overweight/ obese subjects with normal glucose metabolism for 12 weeks Energy intake was matched with estimated energy expenditure |
Period Title: Overall Study | ||||
STARTED | 11 | 7 | 13 | 5 |
COMPLETED | 11 | 7 | 13 | 5 |
NOT COMPLETED | 0 | 0 | 0 | 0 |
Baseline Characteristics
Arm/Group Title | Exercise | Diet | Exercise, Control | Diet, Control | Total |
---|---|---|---|---|---|
Arm/Group Description | An overweight/dysglycemic group 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks | overweight/ obese subjects with normal glucose metabolism with energy restriction, 20% reduced intake of energy from food for 12 weeks | An overweight with no dysglycemia 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks | overweight/ obese subjects with normal glucose metabolism for 12 weeks | Total of all reporting groups |
Overall Participants | 11 | 7 | 13 | 5 | 36 |
Age (years) [Mean (Standard Deviation) ] | |||||
Mean (Standard Deviation) [years] |
53
(1.7)
|
59
(1.3)
|
50
(2.1)
|
57
(2.7)
|
55
(2)
|
Sex: Female, Male (Count of Participants) | |||||
Female |
0
0%
|
4
57.1%
|
0
0%
|
2
40%
|
6
16.7%
|
Male |
11
100%
|
3
42.9%
|
13
100%
|
3
60%
|
30
83.3%
|
Race and Ethnicity Not Collected (Count of Participants) | |||||
Count of Participants [Participants] |
0
0%
|
||||
Region of Enrollment (participants) [Number] | |||||
United Kingdom |
11
100%
|
7
100%
|
13
100%
|
5
100%
|
36
100%
|
BMI (kg/m^2) [Mean (Standard Deviation) ] | |||||
Mean (Standard Deviation) [kg/m^2] |
28.9
(2.5)
|
30.8
(3.1)
|
23.5
(2)
|
29.1
(2)
|
28
(2.3)
|
Fasting glucose (mmol/L) [Mean (Standard Deviation) ] | |||||
Mean (Standard Deviation) [mmol/L] |
5.8
(0.4)
|
5.0
(0.6)
|
5.4
(0.1)
|
4.6
(0.3)
|
5.2
(0.4)
|
Total cholesterol (mg/dL) [Mean (Standard Deviation) ] | |||||
Mean (Standard Deviation) [mg/dL] |
5.6
(0.5)
|
5.6
(1.2)
|
5.1
(0.2)
|
4.9
(0.3)
|
5.2
(0.5)
|
Outcome Measures
Title | Insulin Sensitivity |
---|---|
Description | Glucose Infusion rate assessed by the euglycemic hyperinsulinemic clamp. Insulin Sensitivity assessment was only performed in the "Exercise" and "Exercise, Control" groups. No data were collected for this Outcome from the remaining groups. |
Time Frame | Baseline, 12 weeks |
Outcome Measure Data
Analysis Population Description |
---|
No data available for diet and diet-control group |
Arm/Group Title | Exercise | Diet | Exercise, Control | Diet, Control |
---|---|---|---|---|
Arm/Group Description | An overweight/dysglycemic group 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks | overweight/ obese subjects with normal glucose metabolism with energy restriction, 20% reduced intake of energy from food for 12 weeks | An overweight with no dysglycemia 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks | overweight/ obese subjects with normal glucose metabolism for 12 weeks |
Measure Participants | 11 | 0 | 13 | 0 |
Baseline |
4.2
(1.8)
|
7.6
(1.6)
|
||
12 weeks |
5.4
(1.8)
|
10.4
(2.6)
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Exercise |
---|---|---|
Comments | Baseline vs 12 weeks | |
Type of Statistical Test | Superiority | |
Comments | ||
Statistical Test of Hypothesis | p-Value | <0.05 |
Comments | calculated. The reported p-value was calculated, and is not attempting to indicate the threshold for statistical significance | |
Method | t-test, 2 sided | |
Comments |
Statistical Analysis 2
Statistical Analysis Overview | Comparison Group Selection | Exercise, Control |
---|---|---|
Comments | Baseline vs 12 weeks | |
Type of Statistical Test | Superiority | |
Comments | ||
Statistical Test of Hypothesis | p-Value | <0.05 |
Comments | calculated. The reported p-value was calculated, and is not attempting to indicate the threshold for statistical significance. | |
Method | t-test, 2 sided | |
Comments |
Title | Metabolomic Biomarker Discovery - Changes in Blood Plasma Cholesterol |
---|---|
Description | Changes in blood plasma cholesterol in mg/dL- baseline to 12 weeks, after treatment. Statistical Analysis was performed only for the "Diet" Arm/Group. |
Time Frame | Baseline, 12 weeks |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Exercise | Diet | Exercise, Control | Diet, Control |
---|---|---|---|---|
Arm/Group Description | An overweight/dysglycemic group 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks | overweight/ obese subjects with normal glucose metabolism with energy restriction, 20% reduced intake of energy from food for 12 weeks | An overweight with no dysglycemia 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks | overweight/ obese subjects with normal glucose metabolism for 12 weeks |
Measure Participants | 11 | 7 | 13 | 5 |
Baseline |
5.6
(0.5)
|
5.6
(1.2)
|
5.1
(0.2)
|
4.9
(0.3)
|
12 weeks |
5.8
(0.7)
|
4.9
(1.3)
|
4.9
(0.1)
|
5.1
(0.3)
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Diet |
---|---|---|
Comments | Baseline vs 12 weeks. Statistical Analysis was performed only for the "Diet" Arm/Group. | |
Type of Statistical Test | Superiority | |
Comments | Statistical Analysis was performed only for the "Diet" Arm/Group | |
Statistical Test of Hypothesis | p-Value | <0.05 |
Comments | calculated. The reported p-value was calculated, and is not attempting to indicate the threshold for statistical significance | |
Method | t-test, 2 sided | |
Comments |
Title | Body Composition |
---|---|
Description | Body Composition assessed by BMI |
Time Frame | Baseline, 12 weeks |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Exercise | Diet | Exercise, Control | Diet, Control |
---|---|---|---|---|
Arm/Group Description | An overweight/dysglycemic group 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks | overweight/ obese subjects with normal glucose metabolism with energy restriction, 20% reduced intake of energy from food for 12 weeks | An overweight with no dysglycemia 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks | overweight/ obese subjects with normal glucose metabolism for 12 weeks |
Measure Participants | 11 | 7 | 13 | 5 |
Baseline |
28.9
(2.5)
|
30.8
(3.1)
|
23.5
(2)
|
29.1
(2)
|
12 weeks |
28.6
(2.4)
|
29.2
(3)
|
23.5
(1.8)
|
29.1
(2)
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Diet |
---|---|---|
Comments | Baseline vs 12 weeks. Statistical Analysis was performed only for the "Diet" Arm/Group. | |
Type of Statistical Test | Superiority | |
Comments | Statistical Analysis was performed only for the "Diet" Arm/Group | |
Statistical Test of Hypothesis | p-Value | <0.05 |
Comments | calculated. The reported p-value was calculated, and is not attempting to indicate the threshold for statistical significance. | |
Method | t-test, 2 sided | |
Comments |
Title | Changes in Adipocyte Morphology |
---|---|
Description | Percentage Change in total adipose tissue assessed by MRI |
Time Frame | 12 weeks |
Outcome Measure Data
Analysis Population Description |
---|
1 missing data in diet group |
Arm/Group Title | Exercise | Diet | Exercise, Control | Diet, Control |
---|---|---|---|---|
Arm/Group Description | An overweight/dysglycemic group 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks | overweight/ obese subjects with normal glucose metabolism with energy restriction, 20% reduced intake of energy from food for 12 weeks | An overweight with no dysglycemia 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks | overweight/ obese subjects with normal glucose metabolism for 12 weeks |
Measure Participants | 7 | 6 | 13 | 5 |
Mean (Standard Error) [percentage change] |
-10.9
(5.1)
|
-8.9
(3.3)
|
-8.5
(2.7)
|
3.7
(1.4)
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Exercise |
---|---|---|
Comments | Baseline vs 12 weeks | |
Type of Statistical Test | Superiority | |
Comments | ||
Statistical Test of Hypothesis | p-Value | <0.05 |
Comments | The reported p-value was calculated, and is not attempting to indicate the threshold for statistical significance | |
Method | t-test, 2 sided | |
Comments |
Statistical Analysis 2
Statistical Analysis Overview | Comparison Group Selection | Diet |
---|---|---|
Comments | Baseline vs 12 weeks | |
Type of Statistical Test | Superiority | |
Comments | ||
Statistical Test of Hypothesis | p-Value | <0.05 |
Comments | The reported p-value was calculated, and is not attempting to indicate the threshold for statistical significance | |
Method | t-test, 2 sided | |
Comments |
Statistical Analysis 3
Statistical Analysis Overview | Comparison Group Selection | Exercise, Control |
---|---|---|
Comments | Baseline vs 12 weeks | |
Type of Statistical Test | Superiority | |
Comments | ||
Statistical Test of Hypothesis | p-Value | <0.05 |
Comments | The reported p-value was calculated, and is not attempting to indicate the threshold for statistical significance | |
Method | t-test, 2 sided | |
Comments |
Title | Genome Integrity (DNA Methylation and Telomere Length) |
---|---|
Description | |
Time Frame | 12 weeks |
Outcome Measure Data
Analysis Population Description |
---|
Data not collected |
Arm/Group Title | Exercise | Diet | Exercise, Control | Diet, Control |
---|---|---|---|---|
Arm/Group Description | An overweight/dysglycemic group 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks | overweight/ obese subjects with normal glucose metabolism with energy restriction, 20% reduced intake of energy from food for 12 weeks | An overweight with no dysglycemia 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks | overweight/ obese subjects with normal glucose metabolism for 12 weeks |
Measure Participants | 0 | 0 | 0 | 0 |
Title | Body Weight |
---|---|
Description | |
Time Frame | Baseline, 12 weeks |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Exercise | Diet | Exercise, Control | Diet, Control |
---|---|---|---|---|
Arm/Group Description | An overweight/dysglycemic group 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks | overweight/ obese subjects with normal glucose metabolism with energy restriction, 20% reduced intake of energy from food for 12 weeks | An overweight with no dysglycemia 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks | overweight/ obese subjects with normal glucose metabolism for 12 weeks |
Measure Participants | 11 | 7 | 13 | 5 |
Baseline |
92.9
(9)
|
91.9
(17.8)
|
78.5
(2.3)
|
84.7
(4.8)
|
12 weeks |
91.6
(9.1)
|
87.3
(17.4)
|
78.3
(2.3)
|
84.5
(4.9)
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Diet |
---|---|---|
Comments | Baseline vs 12 weeks. Statistical Analysis was performed only for the "Diet" Arm/Group. | |
Type of Statistical Test | Superiority | |
Comments | Statistical Analysis was performed only for the "Diet" Arm/Group | |
Statistical Test of Hypothesis | p-Value | <0.05 |
Comments | calculated. The reported p-value was calculated, and is not attempting to indicate the threshold for statistical significance | |
Method | t-test, 2 sided | |
Comments |
Adverse Events
Time Frame | 12 weeks | |||||||
---|---|---|---|---|---|---|---|---|
Adverse Event Reporting Description | ||||||||
Arm/Group Title | Exercise | Diet | Exercise, Control | Diet, Control | ||||
Arm/Group Description | An overweight/dysglycemic group 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks | overweight/ obese subjects with normal glucose metabolism with energy restriction, 20% reduced intake of energy from food for 12 weeks | An overweight with no dysglycemia 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks | overweight/ obese subjects with normal glucose metabolism for 12 weeks | ||||
All Cause Mortality |
||||||||
Exercise | Diet | Exercise, Control | Diet, Control | |||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/11 (0%) | 0/7 (0%) | 0/13 (0%) | 0/5 (0%) | ||||
Serious Adverse Events |
||||||||
Exercise | Diet | Exercise, Control | Diet, Control | |||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/11 (0%) | 0/7 (0%) | 0/13 (0%) | 0/5 (0%) | ||||
Other (Not Including Serious) Adverse Events |
||||||||
Exercise | Diet | Exercise, Control | Diet, Control | |||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/11 (0%) | 0/7 (0%) | 0/13 (0%) | 0/5 (0%) |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Professor Gary Frost |
---|---|
Organization | Imperial College London |
Phone | +44 (0)20 7594 0959 |
g.frost@imperial.ac.uk |
- 12/L0/0139